RYOIX - Rydex Biotechnology Inv

Nasdaq - Nasdaq Delayed Price. Currency in USD

Rydex Biotechnology Inv

Rydex Series Funds9601 Blackwell Road,Suite 500Rockville, MD 20850
800-820-0888
Management Information
Michael P. Byrum,Lead Manager since March 31, 1998
Michael P. Byrum, CFA, Senior Vice President. He has been associated with the Advisor since it was founded in 1993. During this time, he has played a key role in the development of the firm’s investment strategies and product offerings. He was named Vice President of Portfolio for the Advisor in 1998, and Executive Vice President in 2000. Prior to joining the Advisor, Mr. Byrum worked for Money Management Associates, the investment adviser for Rushmore Funds, Inc. He holds a degree in finance from Miami University of Ohio and is a member of the CFA Institute and the Washington Society of Investment Analysts.
Morningstar Style Box
Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund.
Morningstar Category
While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk, and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. When necessary, we may change a category assignment based on recent changes to the portfolio.

Fund Overview

CategoryHealth
Fund FamilyRydex Funds
Net Assets384.91M
YTD Return26.94%
Yield0.00%
Morningstar Rating★★★
Inception DateMar 31, 1998

Fund Operations

Last Dividend0.00
Last Cap Gain0.00
Holdings Turnover207.00%
Average for CategoryN/A

Fees & Expenses

ExpenseRYOIXCategory Average
Annual Report Expense Ratio (net)1.37%1.32%
Prospectus Net Expense Ratio1.37%N/A
Prospectus Gross Expense Ratio1.37%N/A
Max 12b1 FeeN/AN/A
Max Front End Sales LoadN/A5.30%
Max Deferred Sales LoadN/A1.85%
3 Yr Expense Projection434N/A
5 Yr Expense Projection750N/A
10 Yr Expense Projection1,646N/A